Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David B Volkin

Showing results (51-60 of 175) with videos related to

Pageof 18
Sort By:
AAPS Pharmscitech|April 20, 2023
Comparison of Protein Particle Formation in IgG1 mAbs Formulated with PS20 Vs. PS80 When Subjected to Interfacial Dilatational StressColeman Vaclaw, Kimberly Merritt, Valerie P Griffin, et al.
Journal of Pharmaceutical Sciences|October 22, 2013
Linking the solution viscosity of an IgG2 monoclonal antibody to its structure as a function of pH and temperatureWeiqiang Cheng, Sangeeta B Joshi, Nishant Kumar Jain, et al.
Journal of Pharmaceutical Sciences|June 14, 2019
Characterization of Excipient Effects on Reversible Self-Association, Backbone Flexibility, and Solution Properties of an IgG1 Monoclonal Antibody at High Concentrations: Part 2Yue Hu, Ronald T Toth, Sangeeta B Joshi, et al.
Journal of Pharmaceutical Sciences|February 9, 2018
Development of Stabilizing Formulations of a Trivalent Inactivated Poliovirus Vaccine in a Dried State for Delivery in the Nanopatch™ Microprojection ArrayYing Wan, John M Hickey, Christopher Bird, et al.
Journal of Pharmaceutical Sciences|October 11, 2014
Calculating the mass of subvisible protein particles with improved accuracy using microflow imaging dataCavan Kalonia, Ozan S Kumru, Indira Prajapati, et al.
Journal of Pharmaceutical Sciences|November 7, 2021
Evaluating the Combined Impact of Temperature and Application of Interfacial Dilatational Stresses on Surface-mediated Protein Particle Formation in Monoclonal Antibody FormulationsValerie P Griffin, Kimberly Merritt, Coleman Vaclaw, et al.
Journal of Pharmaceutical Sciences|January 24, 2014
Structural characterization of IgG1 mAb aggregates and particles generated under various stress conditionsSrivalli N Telikepalli, Ozan S Kumru, Cavan Kalonia, et al.
Mabs|December 20, 2014
Correlations between changes in conformational dynamics and physical stability in a mutant IgG1 mAb engineered for extended serum half-lifeRanajoy Majumdar, Reza Esfandiary, Steven M Bishop, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|April 14, 2016
Challenges and opportunities of using liquid chromatography and mass spectrometry methods to develop complex vaccine antigens as pharmaceutical dosage formsJohn M Hickey, Neha Sahni, Ronald T Toth, et al.
Vaccine|May 29, 2017
Development of a candidate stabilizing formulation for bulk storage of a double mutant heat labile toxin (dmLT) protein based adjuvantVishal M Toprani, Neha Sahni, John M Hickey, et al.
Pageof 18

Showing results (51-60 of 175) with videos related to

Sort By:
Pageof 18
AAPS Pharmscitech|April 20, 2023
Comparison of Protein Particle Formation in IgG1 mAbs Formulated with PS20 Vs. PS80 When Subjected to Interfacial Dilatational StressColeman Vaclaw, Kimberly Merritt, Valerie P Griffin, et al.
Journal of Pharmaceutical Sciences|October 22, 2013
Linking the solution viscosity of an IgG2 monoclonal antibody to its structure as a function of pH and temperatureWeiqiang Cheng, Sangeeta B Joshi, Nishant Kumar Jain, et al.
Journal of Pharmaceutical Sciences|June 14, 2019
Characterization of Excipient Effects on Reversible Self-Association, Backbone Flexibility, and Solution Properties of an IgG1 Monoclonal Antibody at High Concentrations: Part 2Yue Hu, Ronald T Toth, Sangeeta B Joshi, et al.
Journal of Pharmaceutical Sciences|February 9, 2018
Development of Stabilizing Formulations of a Trivalent Inactivated Poliovirus Vaccine in a Dried State for Delivery in the Nanopatch™ Microprojection ArrayYing Wan, John M Hickey, Christopher Bird, et al.
Journal of Pharmaceutical Sciences|October 11, 2014
Calculating the mass of subvisible protein particles with improved accuracy using microflow imaging dataCavan Kalonia, Ozan S Kumru, Indira Prajapati, et al.
Journal of Pharmaceutical Sciences|November 7, 2021
Evaluating the Combined Impact of Temperature and Application of Interfacial Dilatational Stresses on Surface-mediated Protein Particle Formation in Monoclonal Antibody FormulationsValerie P Griffin, Kimberly Merritt, Coleman Vaclaw, et al.
Journal of Pharmaceutical Sciences|January 24, 2014
Structural characterization of IgG1 mAb aggregates and particles generated under various stress conditionsSrivalli N Telikepalli, Ozan S Kumru, Cavan Kalonia, et al.
Mabs|December 20, 2014
Correlations between changes in conformational dynamics and physical stability in a mutant IgG1 mAb engineered for extended serum half-lifeRanajoy Majumdar, Reza Esfandiary, Steven M Bishop, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|April 14, 2016
Challenges and opportunities of using liquid chromatography and mass spectrometry methods to develop complex vaccine antigens as pharmaceutical dosage formsJohn M Hickey, Neha Sahni, Ronald T Toth, et al.
Vaccine|May 29, 2017
Development of a candidate stabilizing formulation for bulk storage of a double mutant heat labile toxin (dmLT) protein based adjuvantVishal M Toprani, Neha Sahni, John M Hickey, et al.
Pageof 18